ATE440836T1 - Verbindungen - Google Patents

Verbindungen

Info

Publication number
ATE440836T1
ATE440836T1 AT06791540T AT06791540T ATE440836T1 AT E440836 T1 ATE440836 T1 AT E440836T1 AT 06791540 T AT06791540 T AT 06791540T AT 06791540 T AT06791540 T AT 06791540T AT E440836 T1 ATE440836 T1 AT E440836T1
Authority
AT
Austria
Prior art keywords
links
salts
compounds
processes
formula
Prior art date
Application number
AT06791540T
Other languages
English (en)
Inventor
Rachael Ancliff
Mark Bamford
Simon Hodgson
Christopher Parr
Panayiotis Procopiou
David Wilson
Michael Woodrow
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE440836T1 publication Critical patent/ATE440836T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT06791540T 2005-07-19 2006-07-17 Verbindungen ATE440836T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0514811.9A GB0514811D0 (en) 2005-07-19 2005-07-19 Compounds
PCT/EP2006/007034 WO2007009739A1 (en) 2005-07-19 2006-07-17 Compounds

Publications (1)

Publication Number Publication Date
ATE440836T1 true ATE440836T1 (de) 2009-09-15

Family

ID=34897469

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06791540T ATE440836T1 (de) 2005-07-19 2006-07-17 Verbindungen

Country Status (8)

Country Link
US (1) US20080207638A1 (de)
EP (1) EP1904484B1 (de)
JP (1) JP2009501744A (de)
AT (1) ATE440836T1 (de)
DE (1) DE602006008788D1 (de)
ES (1) ES2330472T3 (de)
GB (1) GB0514811D0 (de)
WO (1) WO2007009739A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010005225A (es) 2007-11-13 2010-05-27 Taisho Pharmaceutical Co Ltd Derivados de fenilpirazol.
WO2010068311A1 (en) 2008-05-23 2010-06-17 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein inhibitor
JP5740838B2 (ja) * 2009-05-12 2015-07-01 大正製薬株式会社 フェニルピラゾール誘導体
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
JP6110611B2 (ja) 2012-07-18 2017-04-05 株式会社東芝 アミンの回収方法および分析方法
KR20170003673A (ko) 2014-05-12 2017-01-09 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 감염성 질환을 치료하기 위한 다니릭신을 포함하는 약제 조성물
EP4125919A1 (de) 2020-03-26 2023-02-08 GlaxoSmithKline Intellectual Property Development Limited Cathepsinhemmer zur vorbeugung oder behandlung von virusinfektionen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19614204A1 (de) * 1996-04-10 1997-10-16 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
US6620839B2 (en) * 2000-07-13 2003-09-16 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
PT1301480E (pt) * 2000-07-13 2007-11-29 Abbott Lab Pirrolidinas 1,3-di-substituídas e 1,3,3-tri-substituídas úteis como ligandos do receptor de histamina-3 e suas aplicações terapêuticas
GB0224084D0 (en) * 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
GB0514812D0 (en) * 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
US20080207638A1 (en) 2008-08-28
DE602006008788D1 (de) 2009-10-08
WO2007009739A1 (en) 2007-01-25
EP1904484A1 (de) 2008-04-02
ES2330472T3 (es) 2009-12-10
EP1904484B1 (de) 2009-08-26
GB0514811D0 (en) 2005-08-24
JP2009501744A (ja) 2009-01-22

Similar Documents

Publication Publication Date Title
EA201001821A1 (ru) Производные триазола, полезные для лечения заболеваний
EA200801996A1 (ru) 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
EA200870282A1 (ru) Производные амина
EA200601223A1 (ru) Производные сульфонамида для лечения заболеваний
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
WO2006100081A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
EA201100503A1 (ru) Глюкозидные производные и их применения
CR9347A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
TW200738659A (en) Novel compounds
NO20082096L (no) Azaindol-2-karboksamidderivativer
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
HK1116477A1 (en) Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders
ATE440836T1 (de) Verbindungen
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
WO2008074803A8 (en) 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists
ATE517873T1 (de) 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten
ATE521609T1 (de) Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs
BRPI0508927A (pt) compostos úteis para o tratamento de doenças
BRPI0509667B8 (pt) composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto
GB0609897D0 (en) Compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties